We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.14B
AUM Growth
+$472M
Cap. Flow
-$185M
Cap. Flow %
-2.28%
Top 10 Hldgs %
22.23%
Holding
635
New
20
Increased
297
Reduced
290
Closed
18

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.3M
2
BX icon
Blackstone
BX
+$12.2M
3
TFC icon
Truist Financial
TFC
+$11.5M
4
WTRG icon
Essential Utilities
WTRG
+$9.5M
5
LIN icon
Linde
LIN
+$9.49M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$29.1M
2
CELG
Celgene Corp
CELG
+$19.6M
3
ABT icon
Abbott
ABT
+$16.9M
4
ITW icon
Illinois Tool Works
ITW
+$16.6M
5
AMT icon
American Tower
AMT
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 21.12%
2 Financials 15.73%
3 Healthcare 14.13%
4 Communication Services 10.46%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$191B
$62.3M 0.76%
455,530
-38,400
-8% -$5.23M
CSCO icon
27
Cisco
CSCO
$448B
$61.7M 0.76%
1,286,908
+11,800
+0.9% +$548K
CMCSA icon
28
Comcast
CMCSA
$84B
$60.5M 0.74%
1,346,148
+46,800
+4% +$2.08M
C icon
29
Citigroup
C
$222B
$52.8M 0.65%
660,906
-34,800
-5% -$2.57M
ADBE icon
30
Adobe
ADBE
$98.5B
$48.5M 0.59%
146,916
+300
+0.2% +$88.3K
INTC icon
31
Intel
INTC
$460B
$46.9M 0.58%
783,754
-519,484
-40% -$29.1M
MDT icon
32
Medtronic
MDT
$110B
$44.9M 0.55%
395,662
+5,600
+1% +$615K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.1T
$44.5M 0.55%
196,546
-5,600
-3% -$1.22M
BMY icon
34
Bristol-Myers Squibb
BMY
$132B
$43.8M 0.54%
681,655
+214,816
+46% +$12.3M
MCD icon
35
McDonald's
MCD
$191B
$43.6M 0.54%
220,862
-5,100
-2% -$1.01M
AMGN icon
36
Amgen
AMGN
$209B
$42M 0.52%
174,045
+3,900
+2% +$860K
CRM icon
37
Salesforce
CRM
$148B
$41.1M 0.5%
252,597
-4,900
-2% -$768K
NFLX icon
38
Netflix
NFLX
$305B
$40.8M 0.5%
1,261,500
-9,000
-0.7% -$267K
ACN icon
39
Accenture
ACN
$99.9B
$40.3M 0.49%
191,394
-8,100
-4% -$1.58M
COST icon
40
Costco
COST
$423B
$40.2M 0.49%
136,640
-3,400
-2% -$1.01M
NVDA icon
41
NVIDIA
NVDA
$4.72T
$39.7M 0.49%
6,750,440
+244,000
+4% +$1.27M
ABBV icon
42
AbbVie
ABBV
$455B
$38.6M 0.47%
435,979
-2,200
-0.5% -$183K
ORCL icon
43
Oracle
ORCL
$367B
$38.5M 0.47%
727,113
-5,100
-0.7% -$281K
TMO icon
44
Thermo Fisher Scientific
TMO
$214B
$38.5M 0.47%
118,576
+1,500
+1% +$455K
AVGO icon
45
Broadcom
AVGO
$1.85T
$37.9M 0.47%
1,200,560
+52,000
+5% +$1.58M
NKE icon
46
Nike
NKE
$62.7B
$37.6M 0.46%
370,661
-16,800
-4% -$1.58M
IBM icon
47
IBM
IBM
$209B
$36.4M 0.45%
283,972
-6,799
-2% -$884K
PYPL icon
48
PayPal
PYPL
$49.3B
$35M 0.43%
323,388
-5,500
-2% -$573K
LLY icon
49
Eli Lilly
LLY
$1.03T
$32.5M 0.4%
246,990
+7,800
+3% +$904K
QCOM icon
50
Qualcomm
QCOM
$160B
$31.8M 0.39%
360,455
+6,700
+2% +$561K

Similar funds

Fjarde Ap-fonden's Q4 2019 Portfolio in Review

As of Q4 2019, Fjarde Ap-fonden held 635 positions worth $8.14B, up 6.1% from $7.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Fjarde Ap-fonden's Q4 2019 filing shows 20 new, 297 increased, 290 reduced and 18 closed positions. Its largest new stake was Blackstone: 236,100 shares worth $13.2M. The largest sale was Intel, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Fjarde Ap-fonden's largest Q4 2019 buy was Blackstone: 236,100 shares worth $13.2M.
  • Fjarde Ap-fonden added most to Bristol-Myers Squibb in Q4 2019, an estimated $12.3M increase.
  • Fjarde Ap-fonden's biggest Q4 2019 reduction was Intel, cutting an estimated $29.1M.
  • Fjarde Ap-fonden fully exited Celgene Corp in Q4 2019, selling an estimated $19.6M.
  • Fjarde Ap-fonden's ten largest holdings make up 22% of its $8.14B portfolio in Q4 2019.
  • Fjarde Ap-fonden opened 20 new positions and closed 18 in Q4 2019.
  • Fjarde Ap-fonden's portfolio value rose 6.1% quarter-over-quarter to $8.14B.

Based on Fjarde Ap-fonden's 13F filing for Q4 2019, filed 10 Feb 2020.